Answers are grounded in this paper and cite their sources.
Meta-analysis evaluates depressive symptom changes in patients using antiseizure medications, suggesting informed prescribing.
With few studies systematically quantifying depressive symptom changes across antiseizure medications (ASMs), this meta-analysis evaluates pre- to post-treatment differences in Beck Depression Inventory (BDI-II) scores using standardized effect sizes with the aim to clarify the differential psychiatric effects of ASMs and support more holistic, patient-centered prescribing.
No takes yet. Share an insight, caveat, or question.
Abdul et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: